2012 Aarkstore.com | ImmunoGen, Inc. – Product Pipeline Review – 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
ImmunoGen, Inc. – Product Pipeline Review – 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s pharmaceuticals report, “ImmunoGen, Inc. - Product
Pipeline Review - 2012” provides data on the ImmunoGen, Inc.’s research and
development focus. The report includes information on current developmental
pipeline, complete with latest updates, and features on discontinued and dormant
projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, ImmunoGen, Inc.’s corporate website, SEC filings, investor
presentations and featured press releases, both from ImmunoGen, Inc. and industry-
specific third party sources, put together by Global Markets Direct’s team.
Scope
- ImmunoGen, Inc. - Brief ImmunoGen, Inc. overview including business description,
key information and facts, and its locations and subsidiaries.
- Review of current pipeline of ImmunoGen, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
Table of contents:

2. List of Tables 5
List of Figures 6
ImmunoGen, Inc. Snapshot 7
ImmunoGen, Inc. Overview 7
Key Information 7
Key Facts 7
ImmunoGen, Inc. – Research and Development Overview 8
Key Therapeutic Areas 8
ImmunoGen, Inc. – Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products – Monotherapy 12
Pipeline Products – Combination Treatment Modalities 13
ImmunoGen, Inc. – Pipeline Products Glance 14
ImmunoGen, Inc. Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Phase I Products/Combination Treatment Modalities 15
ImmunoGen, Inc. – Early Stage Pipeline Products 16
Pre-Clinical Products/Combination Treatment Modalities 16
ImmunoGen, Inc. – Drug Profiles 17
Cancer Program 1 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Cancer Program 2 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Cancer Program 3 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
huHER3-8 20
Product Description 20
Mechanism of Action 20
R&D Progress 20

3. IMGN529 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1
Genta Incorporated – Product Pipeline Review – 2012
Geron Corporation – Product Pipeline Review – 2012
Glenmark Pharmaceuticals Ltd. – Product Pipeline Review – 2012
iBio, Inc. – Product Pipeline Review – 2012
ImmunoGen, Inc. – Product Pipeline Review – 2012
Can-Fite BioPharma Ltd. – Product Pipeline Review – 2012
Celtic Biotech, Ltd. – Product Pipeline Review – 2012
Cyclacel Pharmaceuticals Inc. – Product Pipeline Review – 2012

4. Endocyte, Inc. – Product Pipeline Review – 2012
Flamel Technologies S.A. – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com